Conference
Wednesday, November 4, 2015
- Keynote Speaker: Dr. Jonathan Fitzgerald, Merrimack Pharmaceuticals
"Nal-IRI, Nanoliposomal Irinotecan: From Concept to Positive Phase 3 Results" - Keynote Speaker: Prof. Mansoor M. Amiji, Northeastern University
"Translational Nano-Medicine: Targeted Therapeutic Delivery for Cancer, Pain, and Inflammatory Diseases" - Session I: Preclinical Tools - Changing Landscape of the Pharmaceutical Sciences
- Session II: Nanotechnology in Clinical Trials
- Session III: Regulatory Guidance - Getting Nanopharmaceuticals Approved: From Bench to Clinic
- Session IV: APN - Future Perspective
The Broad Institute
415 Main Street, Cambridge, MA 02142
